Shigeki Kuriyama

9.3k total citations
235 papers, 7.6k citations indexed

About

Shigeki Kuriyama is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Shigeki Kuriyama has authored 235 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 50 papers in Hepatology and 43 papers in Oncology. Recurrent topics in Shigeki Kuriyama's work include Virus-based gene therapy research (37 papers), Liver Disease Diagnosis and Treatment (26 papers) and RNA Interference and Gene Delivery (21 papers). Shigeki Kuriyama is often cited by papers focused on Virus-based gene therapy research (37 papers), Liver Disease Diagnosis and Treatment (26 papers) and RNA Interference and Gene Delivery (21 papers). Shigeki Kuriyama collaborates with scholars based in Japan, Brazil and United States. Shigeki Kuriyama's co-authors include Hitoshi Yoshiji, Hiroshi Fukui, Hirohisa Tsujinoue, Chris E. Talsness, Junichi Yoshii, Yasuhide Ikenaka, Ryuichi Noguchi, Tsutomu Masaki, Toshiya Nakatani and Ibrahim Chahoud and has published in prestigious journals such as Neuron, SHILAP Revista de lepidopterología and Applied Physics Letters.

In The Last Decade

Shigeki Kuriyama

233 papers receiving 7.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeki Kuriyama Japan 46 2.5k 1.8k 1.5k 1.2k 984 235 7.6k
Wilfried Bursch Austria 38 4.4k 1.8× 978 0.5× 1.8k 1.2× 1.5k 1.3× 268 0.3× 91 7.8k
Mehmet Öztürk Türkiye 45 4.1k 1.7× 573 0.3× 910 0.6× 2.8k 2.4× 332 0.3× 200 8.5k
Shuqun Cheng China 41 1.7k 0.7× 2.5k 1.4× 1.4k 0.9× 799 0.7× 320 0.3× 202 5.4k
Thomas Kietzmann Germany 50 5.7k 2.3× 711 0.4× 1.3k 0.9× 876 0.7× 204 0.2× 177 10.9k
Wendong Huang United States 58 5.6k 2.3× 1.2k 0.7× 2.4k 1.6× 3.7k 3.1× 175 0.2× 179 12.1k
Giovanni Gaudino Italy 47 4.1k 1.7× 2.5k 1.4× 594 0.4× 1.8k 1.5× 136 0.1× 112 9.6k
Matías A. Ávila Spain 58 4.9k 2.0× 1.8k 1.0× 2.4k 1.6× 1.5k 1.2× 67 0.1× 220 9.8k
Peter T. Clayton United Kingdom 61 5.4k 2.2× 258 0.1× 592 0.4× 1.2k 1.0× 437 0.4× 238 11.5k
Dongmei Gao China 45 3.0k 1.2× 488 0.3× 455 0.3× 1.4k 1.2× 582 0.6× 217 6.8k

Countries citing papers authored by Shigeki Kuriyama

Since Specialization
Citations

This map shows the geographic impact of Shigeki Kuriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeki Kuriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeki Kuriyama more than expected).

Fields of papers citing papers by Shigeki Kuriyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeki Kuriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeki Kuriyama. The network helps show where Shigeki Kuriyama may publish in the future.

Co-authorship network of co-authors of Shigeki Kuriyama

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeki Kuriyama. A scholar is included among the top collaborators of Shigeki Kuriyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeki Kuriyama. Shigeki Kuriyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodrigues‐da‐Silva, Rodrigo Nunes, et al.. (2023). Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants. Viruses. 15(4). 923–923. 4 indexed citations
2.
Kuriyama, Shigeki, et al.. (2022). Boosting SARS-CoV-2 detection combining pooling and multiplex strategies. Scientific Reports. 12(1). 3 indexed citations
3.
4.
Yoshiji, Hitoshi, Shigeki Kuriyama, & Hiroshi Fukui. (2007). Blockade of renin–angiotensin system in antifibrotic therapy. Journal of Gastroenterology and Hepatology. 22(s1). S93–5. 50 indexed citations
5.
Deguchi, Kazushi, Iwao Sasaki, Kazushi Ikeda, et al.. (2006). The validity of a hyperventilation test for an investigation of autonomic failure: assessment in patients with multiple system atrophy and Parkinson's disease. International Journal of Clinical Practice. 60(12). 1542–1547. 6 indexed citations
6.
7.
Kuriyama, Shigeki & Hitoshi Yoshiji. (2005). New perspectives in cancer research and therapy 2005. 6 indexed citations
8.
Masaki, Tsutomu, Masaaki Tokuda, Shuhei Yoshida, et al.. (2005). Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. International Journal of Oncology. 26(3). 661–71. 32 indexed citations
9.
Tsujimoto, Tatsuhiro, et al.. (2004). Mediastinal Pancreatic Pseudocyst Caused by Obstruction of the Pancreatic Duct Was Eliminated by Bromhexine Hydrochloride. Internal Medicine. 43(11). 1034–1038. 14 indexed citations
10.
Yoshiji, Hitoshi, Shigeki Kuriyama, Ryuichi Noguchi, & Hiroshi Fukui. (2004). Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy. Current Cancer Drug Targets. 4(7). 555–567. 40 indexed citations
11.
Masaki, Tsutomu, Yasushi Shiratori, Michiko Yamagata, et al.. (2003). Cyclins and Cyclin–Dependent Kinases: Comparative Study of Hepatocellular Carcinoma Versus Cirrhosis. Hepatology. 37(3). 534–543. 176 indexed citations
12.
Akahane, Takemi, et al.. (2003). Atrial fibrillation induced by simvastatin treatment in a 61-year-old man. Heart and Vessels. 18(3). 157–159. 6 indexed citations
13.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2002). Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma. Hepatology. 35(4). 834–842. 126 indexed citations
14.
Yoneda, Satoshi, Hitoshi Yoshiji, Shigeki Kuriyama, et al.. (2002). Stage I mantle-cell lymphoma that was difficult to differentiate from abdominal tuberculous lymphadenitis and metastatic pancreatic cancer. Journal of Gastroenterology. 37(10). 859–862. 2 indexed citations
15.
Paumgartten, Francisco José Roma, et al.. (2002). Evaluation of the developmental toxicity of annatto in the rat. Food and Chemical Toxicology. 40(11). 1595–1601. 42 indexed citations
16.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2001). Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology. 34(4). 745–750. 334 indexed citations
17.
Tsujinoue, Hirohisa, Shigeki Kuriyama, Keiichi Tominaga, et al.. (2001). Intravenous readministration of an adenoviral vector performed long after the initial administration failed to induce re-expression of the original transgene in rats. International Journal of Oncology. 18(3). 575–80. 7 indexed citations
18.
Tsujimoto, Tatsuhiro, Shigeki Kuriyama, Masahide Yoshikawa, et al.. (2000). A CASE OF PEMPHIGUS VULGARIS INVOLVING THE EISOPHAGUS. Acta gastro-enterologica belgica. 42(1). 20–26. 2 indexed citations
19.
Okamoto, Shingo, Yukiko Izumi, Akiko Hosokawa, et al.. (1998). AN ADULT CASE OF CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY ASSOCIATED WITH BILATERAL ADRENAL MYELOLIPOMA : AN 8-YEAR OBSERVATION OF CLINICAL CHARACTERISTICS DURING STEROID REPLACEMENT THERAPY. 49(2). 147–155. 1 indexed citations
20.
Tamura, Masakazu, et al.. (1998). Improvement of Retroviral Packaging Cell Lines by Introducing the Polyomavirus Early Region. Human Gene Therapy. 9(2). 161–172. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wilfried Bursch Breakdown of academic impact, for papers by Mehmet Öztürk Breakdown of academic impact, for papers by Shuqun Cheng Breakdown of academic impact, for papers by Thomas Kietzmann Breakdown of academic impact, for papers by Wendong Huang Breakdown of academic impact, for papers by Giovanni Gaudino Breakdown of academic impact, for papers by Matías A. Ávila Breakdown of academic impact, for papers by Peter T. Clayton Breakdown of academic impact, for papers by Dongmei Gao
Rankless by CCL
2026